{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:27:17Z","timestamp":1790008037025,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.tvjl.2016.05.012","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T02:51:58Z","timestamp":1464403918000},"page":"38-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Minimal residual disease in canine lymphoma: An objective marker to assess tumour cell burden in remission"],"prefix":"10.1016","volume":"215","author":[{"given":"Masahiko","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Goto-Koshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Setoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2016.05.012_bib0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tvjl.2014.03.006","article-title":"Minimal residual disease detection by flow cytometry and PARR in lymph node, peripheral blood and bone marrow, following treatment of dogs with diffuse large B-cell lymphoma","volume":"200","author":"Aresu","year":"2014","journal-title":"The Veterinary Journal"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1939-1676.2009.0289.x","article-title":"Asparaginase and MOPP treatment of dogs with lymphoma","volume":"23","author":"Brodsky","year":"2009","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0020","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","article-title":"Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia","volume":"107","author":"Bruggemann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1354\/vp.40-1-32","article-title":"Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes","volume":"40","author":"Burnett","year":"2003","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1476-5829.2012.00324.x","article-title":"Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma","volume":"11","author":"Burton","year":"2012","journal-title":"Veterinary and Comparative Oncology"},{"issue":"Suppl. 1","key":"10.1016\/j.tvjl.2016.05.012_bib0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11259-006-0062-4","article-title":"PCR assessment of minimal residual disease in 8 lymphoma-affected dogs","volume":"30","author":"Calzolari","year":"2006","journal-title":"Veterinary Research Communications"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0040","first-page":"159","article-title":"Treatment of lymphoma and leukemia with cyclophosphamide, vincristine, and prednisone: I. Treatment of dog","volume":"19","author":"Cotter","year":"1983","journal-title":"Journal of the American Animal Hospital Association"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0045","article-title":"Retrospective analysis for the treatment of na\u00efve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol","author":"Curran","year":"2015","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1939-1676.2006.tb02868.x","article-title":"A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma","volume":"20","author":"Frimberger","year":"2006","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0055","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1939-1676.2002.tb02411.x","article-title":"Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma","volume":"16","author":"Garrett","year":"2002","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mcp.2009.07.006","article-title":"Real-time quantitative PCR using hairpin-shaped clone-specific primers for minimal residual disease assessment in an animal model of human non-Hodgkin lymphoma","volume":"24","author":"Gentilini","year":"2010","journal-title":"Molecular and Cellular Probes"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.vetimm.2013.03.012","article-title":"Retrospective monitoring of minimal residual disease using hairpin-shaped clone specific primers in B-cell lymphoma affected dogs","volume":"153","author":"Gentilini","year":"2013","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0070","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/1097-0142(19900801)66:3<480::AID-CNCR2820660314>3.0.CO;2-X","article-title":"Lymphomas in dogs. A morphologic, immunologic, and clinical study","volume":"66","author":"Greenlee","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0075","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1939-1676.2007.tb01959.x","article-title":"Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma","volume":"21","author":"Hosoya","year":"2007","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/10428194.2014.914193","article-title":"Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential","volume":"56","author":"Ito","year":"2014","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5326\/0410221","article-title":"Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma","volume":"41","author":"Jeffreys","year":"2005","journal-title":"Journal of the American Animal Hospital Association"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1939-1676.1993.tb01021.x","article-title":"Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma","volume":"7","author":"Keller","year":"1993","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1939-165X.2004.tb00364.x","article-title":"Detection of neoplastic lymphocytes in peripheral blood of dogs with lymphoma by polymerase chain reaction for antigen receptor gene rearrangement","volume":"33","author":"Keller","year":"2004","journal-title":"Veterinary Clinical Pathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2460\/javma.1998.213.07.985","article-title":"Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma","volume":"213","author":"Khanna","year":"1998","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0105","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2013-06-507319","article-title":"Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program","volume":"122","author":"Ladetto","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1939-1676.2006.tb02864.x","article-title":"Utility of polymerase chain reaction for analysis of antigen receptor rearrangement in staging and predicting prognosis in dogs with lymphoma","volume":"20","author":"Lana","year":"2006","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0115","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1939-1676.2005.tb02753.x","article-title":"Does L-asparaginase influence efficacy or toxicity when added to a standard CHOP protocol for dogs with lymphoma?","volume":"19","author":"MacDonald","year":"2005","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00580-012-1597-0","article-title":"Detection of minimal residual disease (MRD) in canine lymphoma","volume":"23","author":"Manachai","year":"2014","journal-title":"Comparative Clinical Pathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0125","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-13-2283","article-title":"Randomized, placebo-controlled, double-blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large B-cell lymphoma","volume":"20","author":"Marconato","year":"2014","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0130","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood.V82.6.1689.1689","article-title":"Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML\/RAR-\u03b1 fusion mRNA","volume":"82","author":"Miller","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0135","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.leu.2402053","article-title":"Long-term clinical and molecular remission after allogenic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma","volume":"15","author":"Mitterbauer","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.vetimm.2005.02.014","article-title":"Characterization of feline T cell receptor gamma (TCRG) variable region genes for the molecular diagnosis of feline intestinal T cell lymphoma","volume":"106","author":"Moore","year":"2005","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1939-1676.1997.tb00476.x","article-title":"Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma","volume":"11","author":"Myers","year":"1997","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0150","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2005-07-2845","article-title":"Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma","volume":"107","author":"Pott","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-62703-269-8_10","article-title":"MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR","volume":"971","author":"Pott","year":"2013","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0160","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood.V99.3.856","article-title":"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma","volume":"99","author":"Rambaldi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1476-5829.2010.00230.x","article-title":"CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma","volume":"9","author":"Rebhun","year":"2011","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0170","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1200\/JCO.2014.59.7203","article-title":"Revised international pediatric non-Hodgkin lymphoma staging system","volume":"33","author":"Rosolen","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0175","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1200\/JCO.2014.59.0745","article-title":"International pediatric non-Hodgkin lymphoma response criteria","volume":"33","author":"Sandlund","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0180","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1939-1676.2010.0675.x","article-title":"Increase in minimal residual disease (MRD) in peripheral blood before clinical relapse in dogs with lymphoma that achieved complete remission after chemotherapy","volume":"25","author":"Sato","year":"2011","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1939-1676.2011.0686.x","article-title":"Evaluation of cytoreductive efficacy of vincristine, cyclophosphamide, and doxorubicin in dogs with lymphoma by measuring the number of neoplastic lymphoid cells with real-time polymerase chain reaction","volume":"25","author":"Sato","year":"2011","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.tvjl.2012.07.013","article-title":"The prognostic significance of minimal residual disease in the early phases of chemotherapy in dogs with high-grade B-cell lymphoma","volume":"195","author":"Sato","year":"2013","journal-title":"The Veterinary Journal"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0195","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1939-1676.2006.tb01810.x","article-title":"Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol","volume":"20","author":"Simon","year":"2006","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0200","first-page":"196","article-title":"Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases","volume":"8","author":"Sorenmo","year":"2010","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.vetimm.2005.10.009","article-title":"Development of the polymerase chain reaction assay based on the canine genome database for detection of monoclonality in B cell lymphoma","volume":"110","author":"Tamura","year":"2006","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0210","first-page":"79","article-title":"Clonality and phenotyping of canine lymphomas before chemotherapy and during remission using polymerase chain reaction (PCR) on lymph node cytologic smears and peripheral blood","volume":"51","author":"Thilakaratne","year":"2010","journal-title":"Canadian Veterinary Journal"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0215","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1349-7006.2003.tb01370.x","article-title":"Development of consensus fluorogenically labeled probes of the immunoglobulin heavy-chain gene for detecting minimal residual disease in B-cell non-Hodgkin lymphomas","volume":"94","author":"Uchiyama","year":"2003","journal-title":"Cancer Science"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0220","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/sj.leu.2402515","article-title":"T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis","volume":"16","author":"van der Velden","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0225","first-page":"807","article-title":"Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma","volume":"24","author":"Vail","year":"1996","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1354\/vp.43-3-241","article-title":"Canine indolent nodular lymphoma","volume":"43","author":"Valli","year":"2006","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0235","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0300985810379428","article-title":"Classification of canine malignant lymphomas according to the World Health Organization criteria","volume":"48","author":"Valli","year":"2011","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0240","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1354\/vp.42-5-596","article-title":"Characterization of feline immunoglobulin heavy chain variable region genes for the molecular diagnosis of B-cell neoplasia","volume":"42","author":"Werner","year":"2005","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.vetimm.2006.11.005","article-title":"Genomic organization of the T-cell receptor gamma gene and PCR detection of its clonal rearrangement in canine T-cell lymphoma\/leukemia","volume":"115","author":"Yagihara","year":"2007","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0250","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.vetimm.2008.09.004","article-title":"Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction","volume":"126","author":"Yamazaki","year":"2008","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0255","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1939-1676.2010.0536.x","article-title":"Monitoring of minimal residual disease (MRD) after multidrug chemotherapy and its correlation to outcome in dogs with lymphoma: A proof-of-concept study","volume":"24","author":"Yamazaki","year":"2010","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0260","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0145-2126(03)00049-3","article-title":"Quantitative assessment of contaminating tumor cells in autologous peripheral blood stem cells of B-cell non-Hodgkin lymphomas using immunoglobulin heavy chain gene allele-specific oligonucleotide real-time quantitative-polymerase chain reaction","volume":"27","author":"Yashima","year":"2003","journal-title":"Leukemia Research"},{"key":"10.1016\/j.tvjl.2016.05.012_bib0265","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1939-1676.1998.tb02151.x","article-title":"A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma","volume":"12","author":"Zemann","year":"1998","journal-title":"Journal of Veterinary Internal Medicine"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023316300648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023316300648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T06:00:54Z","timestamp":1718604054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023316300648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":52,"alternative-id":["S1090023316300648"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2016.05.012","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal residual disease in canine lymphoma: An objective marker to assess tumour cell burden in remission","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2016.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}